Following our machine learning‐driven approach to panel development, six predictors were present in the final model: four (history of diabetes, BUN/creatinine ratio, CRP, and osteopontin) had a positive association with AKI risk; while two (CD5 antigen‐like and Factor VII) had a negative association with AKI risk. Here, CD5 is linked to diabetes mellitus.